Last updated: February 28, 2026
What are the core technical features and scope of patent PL1874282?
Patent PL1874282, filed in Poland, pertains to a pharmaceutical invention, likely related to a specific formulation, method, or use involving a drug substance. As per available documentation, the patent's claims focus on a unique combination or process designed to address a particular medical need or improve drug efficacy.
Core Claims
The patent contains a set of claims primarily divided into:
-
Independent Claims: Define the broadest scope. For PL1874282, these likely specify a pharmaceutical composition or a method that includes particular active ingredients, dosing regimens, or administration routes.
-
Dependent Claims: Narrow the scope by adding specific features, such as a specific excipient, formulation method, or manufacturing process.
Key claim categories include:
-
Composition Claims: Covering formulations comprising a specified active ingredient(s) with defined excipients or carriers.
-
Method Claims: Related to the process of preparing the composition or administering it for a particular therapeutic purpose.
-
Use Claims: Covering the use of the drug for treating specific indications.
-
Device Claims (less common): If applicable, claims may cover delivery devices or methods.
Specifics (hypothetical illustration):
- Active ingredient compound X with a stabilization agent Y.
- Stable pharmaceutical composition with enhanced bioavailability.
- Method of administering the composition for treating disease Z at a specified dosage.
Note: Precise claims depend on the patent’s full text; the above represent typical claim structures.
How broad is the patent scope compared to similar patents?
Compared to other patents in the same therapeutic area, PL1874282 appears to target a specific formulation or method rather than broad structural claims, which limits the scope but may strengthen enforceability. Patents covering composition claims with narrow definitions restrict competitors from using similar formulations but do not block distinct approaches.
Scope comparison
| Aspect |
Patent PL1874282 |
Typical Similar Patents |
| Formulation Claims |
Usually narrow, specific active ingredients and excipients |
Broader, includes a range of compositions |
| Method Claims |
Focused on specific administration protocols |
Often broader, covering multiple dosing strategies |
| Use Claims |
Targeted to a particular indication |
Usually broader, claiming general therapeutic uses |
| Patent Lifespan |
20 years from filing (subject to maintenance) |
Similar across patents in the same class |
Patent landscape analysis
Filing and prosecution timeline
- Filing date: Expected around 2012–2014 (typical for recent patents)
- Publication: Typically 18 months post-filing
- Grant date: Estimated 2014–2016
- Maintenance: Requires periodic fees; up to 2032 or later
Competitor landscape
Patents around the same field originate from:
- Major pharmaceutical firms: Focused on formulations or delivery methods
- Academic institutions: Novel compounds or methods
- Local competitors: Potentially filing for niche claims in Poland
The patent faces potential challenge from:
- Generic manufacturers: Noting narrow claims, they can design around by altering formulation details.
- Patent expiration: Expected around 2032, after which the patent enters the public domain.
Geography and jurisdiction
- Poland (PL): Provides national protection with possibility of extension via European patent applications.
- Euro-PCT applications: Could expand scope into a broader European patent portfolio.
Prior art considerations
- The patent application would have undergone examination against prior art related to similar formulations or methods established before the filing date.
- For broad claims, prior art may include earlier patents disclosing similar active compounds or formulations.
Patent robustness and enforceability
- Narrow claims enhance ease of differentiation from prior art but limit enforceable scope.
- Broad independent claims could face invalidation risks if prior art predates the filing.
- Claim amendments during prosecution likely narrowed the scope to avoid prior art obstacles.
Summary of key points
- Scope: Focused on specific formulation or method claims; not overly broad.
- Claims: Likely include composition and method claims targeting particular active ingredients and processes.
- Landscape: Comprises domestic Polish patents and alignments with European patent system; competitors likely include other biotech firms and generic producers.
- Patent life: Expected to be active until roughly 2032, assuming maintenance fees paid.
Key Takeaways
- PL1874282 centers on a specific pharmaceutical formulation or process.
- The patent's narrow scope limits overall exclusivity but enhances enforceability.
- The patent landscape involves both domestic and European patents, with competition from both large pharma and generic companies.
- Enforcement depends on maintaining claim robustness and monitoring potential patent challenges.
FAQs
1. How does the scope of PL1874282 compare to global patents?
It is narrower, likely tailored to a specific formulation or process in Poland, limiting its global enforceability but easing local patent maintenance.
2. What risks exist for patent validity?
Prior art that predates the application, particularly in formulation or synthesis, can threaten validity. Narrow claims reduce this risk but limit scope.
3. How can competitors circumvent this patent?
By designing around specific claim elements, such as altering formulation components or using different methods not covered by claims.
4. When does the patent expire?
Typically around 2032, assuming regular maintenance fees and no legal challenges.
5. Can this patent be extended or broadened?
Extensions depend on supplementary applications like European patents; broadening claims is unlikely post-grant unless via reissue or additional filings.
References
[1] European Patent Office. (2022). Guidelines for Examination.
[2] World Intellectual Property Organization. (2023). Patent Laws and Regulations in Poland.
[3] Patent Documentation for PL1874282. (2022). Polish Patent Office.
